The 2021 US IPO market continues to break records. 20 IPOs went public this past week, the most in a single week since the year 2000. New filers have slowed ahead of the August lull, with just one IPO submitting an initial filing. Three issuers postponed,...read more
Tenaya Therapeutics, a preclinical biotech developing multiple therapies to treat heart disease, raised $180 million by offering 12 million shares at $15, within the range of $14 to $16. The company offered 2 million more shares than anticipated. The company's...read more
Tenaya Therapeutics, a preclinical biotech developing multiple therapies to treat heart disease, announced terms for its IPO on Monday. The South San Francisco, CA-based company plans to raise $150 million by offering 10 million shares at a price range of $14...read more
After a record breaking number of deals last week, the IPO market cooled off for the shortened holiday week, with just two micro-cap IPOs raising $45 million. Preclinical RNA biotech Transcode Therapeutics (RNAZ) priced at $4 to...read more
US IPO Weekly Recap: Biotechs pop and Robinhood flops in a record 20 IPO week
The 2021 US IPO market continues to break records. 20 IPOs went public this past week, the most in a single week since the year 2000. New filers have slowed ahead of the August lull, with just one IPO submitting an initial filing. Three issuers postponed,...read more
Heart disease biotech Tenaya Therapeutics prices upsized IPO at $15 midpoint
Tenaya Therapeutics, a preclinical biotech developing multiple therapies to treat heart disease, raised $180 million by offering 12 million shares at $15, within the range of $14 to $16. The company offered 2 million more shares than anticipated. The company's...read more
Heart disease biotech Tenaya Therapeutics sets terms for $150 million IPO
Tenaya Therapeutics, a preclinical biotech developing multiple therapies to treat heart disease, announced terms for its IPO on Monday. The South San Francisco, CA-based company plans to raise $150 million by offering 10 million shares at a price range of $14...read more
US IPO Weekly Recap: Micro-caps lead a quiet 2 IPO week
After a record breaking number of deals last week, the IPO market cooled off for the shortened holiday week, with just two micro-cap IPOs raising $45 million. Preclinical RNA biotech Transcode Therapeutics (RNAZ) priced at $4 to...read more